Get the Stockscreener App
284.74
0.29%
0.81
Pre-market:
284.00
-0.74
-0.26%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $284.74, with a volume of 1.40M.
It is up +0.29% in the last 24 hours and up +4.80% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
See More
Previous Close:
$283.93
Open:
$281.1
24h Volume:
1.40M
Relative Volume:
0.85
Market Cap:
$75.02B
Revenue:
$274.88B
Net Income/Loss:
$6.29B
P/E Ratio:
12.83
EPS:
22.1869
Net Cash Flow:
$8.39B
1W Performance:
+0.11%
1M Performance:
+4.80%
6M Performance:
-6.34%
1Y Performance:
-7.81%
1-Day Range:
$280.80
$285.91
1-Week Range:
$271.78
$292.32
52-Week Range:
$239.51
$350.00
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, CNC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
284.74 | 74.81B | 274.88B | 6.29B | 8.39B | 22.19 |
|
UNH
Unitedhealth Group Inc
|
291.96 | 261.98B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
80.57 | 102.40B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
ELV
Elevance Health Inc
|
291.45 | 62.69B | 199.13B | 5.66B | 3.17B | 25.11 |
|
CNC
Centene Corp
|
44.99 | 21.55B | 178.19B | 2.05B | 1.08B | 4.0447 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Brian Evanko to Succeed David Cordani as CEO of The Cigna Group - Digital Health News
AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries - Yahoo Finance
From 1792 to today: Cigna Group CEO David Cordani on building the future of American health - CNBC
Cigna CEO David M. Cordani to retire - Healthcare Finance News
Victory Capital Management Inc. Has $275.49 Million Position in Cigna Group $CI - MarketBeat
Bernstein SocGen reiterates Cigna stock rating on CEO succession - Investing.com
David Cordani led Cigna for 16 years. Here’s a look back - Modern Healthcare
Cigna appoints Brian Evanko as next CEO - Yahoo Finance
Dimensional Fund Advisors LP Sells 130,581 Shares of Cigna Group $CI - MarketBeat
New CEO at major health insurer with 3K CT employees. ‘Excited to build on our strong foundation’ - Hartford Courant
Insurance moves: Cigna, Hilb Group, Alliant and Willis - Insurance Business
Cigna group: Officer Neville Everett sells $497k in stock - Investing.com
Cigna group executive Jones sells $666,515 in stock By Investing.com - Investing.com Australia
Cigna group executive Jones sells $666,515 in stock - Investing.com South Africa
Bloomfield-based health care giant Cigna's CEO Cordani to retire this year - CT Insider
Insider Selling: Cigna Group (NYSE:CI) Insider Sells 2,307 Shares of Stock - MarketBeat
Cigna Group (CI) executive sells shares and receives new stock awards - Stock Titan
Cigna (CI) CFO granted options and restricted stock with tax share withholding - Stock Titan
Cigna (CI) CAO receives 657 options and new stock awards - Stock Titan
Cigna Group (NYSE: CI) EVP granted new equity awards and tax withholdings filed - Stock Titan
Cigna CEO Succession Puts Evernorth And PBM Priorities In Focus - Yahoo! Finance Canada
Cigna names COO Brian Evanko to succeed David Cordani as CEO - Modern Healthcare
Cigna picks Brian Evanko to succeed David Cordani as CEO - BenefitsPRO
Cigna CEO’s Departure Is The Latest Among Top Health Insurers - Forbes
Piper Sandler Reiterates Overweight on Cigna Group (CI), Lowers Price Target | CI Stock News - GuruFocus
Is It Time To Reassess Cigna Group (CI) After Recent Share Price Stability? - simplywall.st
CI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cigna insider Brian Evanko to succeed retiring CEO David Cordani - CNBC
The Cigna Group Names Brian Evanko CEO - citybiz
Cigna CEO Cordani To Retire, Successor Named At Bloomfield-Based Health Care Giant - dailyvoice.com
Brian Evanko to succeed David Cordani as CEO of Cigna - Healthcare Dive
Cigna Names Brian Evanko CEO as David Cordani Retires - WSJ
Cigna Group (CI) Announces CEO Succession and Board Changes - GuruFocus
Analyst recommendations: Amazon, Paramount, Pinterest, Cigna, Tesla… - marketscreener.com
Barclays Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $303 - 富途牛牛
Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor - Fierce Healthcare
Ex-Dividend Reminder: Eversource Energy, The Cigna Group and American Assets Trust - Nasdaq
Cigna Group (NYSE:CI) Price Target Cut to $370.00 by Analysts at Piper Sandler - MarketBeat
Cigna Stock Falls After CEO Retirement Announcement - Benzinga
Cigna (CI) Announces Leadership Change and Reaffirms 2026 Financ - GuruFocus
Here's Why Cigna (CI) is a Strong Growth Stock - Yahoo Finance
Cigna Lines Up COO Evanko to Succeed Long-Time CEO Cordani - Bloomberg.com
Cigna’s longtime CEO to step down as health insurers face growing scrutiny - MarketWatch
Brian Evanko to be Cigna CEO starting in July - Managed Healthcare Executive
The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer - The Cigna Group Newsroom
Cigna names insider Brian Evanko as CEO - marketscreener.com
Cigna CEO David Cordani to Retire; COO Brian Evanko Named Successor - marketscreener.com
Cigna Announces CEO Succession and Leadership Transition Plan - TipRanks
Cigna CEO Cordani to retire in July 2026, new chief executive named - Hartford Business Journal
Cigna names Brian Evanko as CEO - marketscreener.com
Cigna CEO David Cordani To Retire And Be Replaced By Internal Choice - Forbes
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):